©2025 Stanford Medicine
Heparin and the Reduction of Thrombosis (HART) Trial
Not Recruiting
Trial ID: NCT00779558
Purpose
Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?
Official Title
Heparin and Catheter-related Thrombosis in Neonates and Infants Following Cardiac Surgery
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
* All infants \< 1 year of age undergoing cardiac surgery at Lucile Packard Children's Hospital \& #xA
Exclusion Criteria:
* Known coagulopathy
* History of clinically significant bleeding (GI, cranial, pulmonary)
* Need for therapeutic heparinization
* ECMO
Intervention(s):
drug: Heparin sulfate infusion at 10 units/kg/hour
drug: Placebo infusion
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
David Axelrod
4156072463